{
  "html": "<table border=\"1px\" style=\"width: 100%;\"> <tbody><tr><td>&nbsp;</td>\n\t\t\t\t\t<th>PC Number</th>\n\t\t\t\t\t<th>Date</th>\n\t\t\t\t\t<th>Chapter</th>\n\t\t\t\t\t<th>Bill</th>\n\t\t\t\t\t<th>Dept</th></tr><tr><td style=\"min-width: 120px;\">&nbsp;</td><td>2017-1115</td><td>2017-08-31</td><td></td><td></td><td>,&nbsp; ,&nbsp; ISED,&nbsp; ,&nbsp; </td></tr><tr><td>Act</td><td colspan=\"5\">Patent Act</td></tr><tr><td>Subject</td><td colspan=\"5\">Regulations Amending the Patented Medicines (Notice of Compliance) Regulations, 2017</td></tr><tr><td>Precis</td><td colspan=\"5\" id=\"precis\">Regulations Amending the PATENTED MEDICINES (NOTICE OF COMPLIANCE) REGULATIONS in order to (1) resolve a number of problems by replacing summary prohibition proceedings with full actions to determine patent validity and infringement; (2) expand the scope of the Regulations to cover relevant certificates of supplementary protection, by providing an additional period of protection for new patented pharmaceutical products; (3) expedite proceedings by introducing a limited number of procedural rules, while still leaving the Court broad discretion to manage proceedings; 4) address concerns about how damages arising from delayed generic market entry are currently assessed; and 5) remove barriers that may prevent innovators and generics from litigating certain patents outside the Regulations prior to generic market entry.</td></tr><tr><td>Registration</td><td colspan=\"5\" id=\"registration\"><strong>Registration: </strong>SOR/ 2017-0166  <strong>Publication Date:</strong> 2017-09-20</td></tr><tr><td>Attachments</td><td colspan=\"5\"><a href=\"attachment.php?attach=35022&amp;lang=en\">Attachment</a></td></tr></tbody></table>",
  "pcNumber": "2017-1115",
  "htmlHash": "ed8cac925f126b2640b44c905a81fd1f",
  "attachments": [
    "attachment.php?attach=35022&lang=en"
  ]
}